Basilea Pharmaceutica AG
SIX:BSLN
Wall Street
Price Targets
BSLN Price Targets Summary
Basilea Pharmaceutica AG
According to Wall Street analysts, the average 1-year price target for
BSLN
is 89.9 CHF
with a low forecast of 64.64 CHF and a high forecast of 126 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BSLN's stock price target?
Price Target
89.9
CHF
According to Wall Street analysts, the average 1-year price target for
BSLN
is 89.9 CHF
with a low forecast of 64.64 CHF and a high forecast of 126 CHF.
What is Basilea Pharmaceutica AG's Revenue forecast?
Projected CAGR
12%
For the last 8 years the
compound annual growth rate for
Basilea Pharmaceutica AG's revenue is
15%.
The projected
CAGR
for the next 3 years is
12%.
What is Basilea Pharmaceutica AG's Operating Income forecast?
Projected CAGR
8%
The
compound annual growth rate
of Basilea Pharmaceutica AG's operating income for the next 3 years is
8%.
What is Basilea Pharmaceutica AG's Net Income forecast?
Projected CAGR
0%
The
compound annual growth rate
of Basilea Pharmaceutica AG's net income for the next 3 years is
0%.
You don't have any saved screeners yet
